- Q3 2024 Zydus Lifesciences Ltd Earnings Call TranscriptFeb 09, 2024Earnings
- Q2 2024 Zydus Lifesciences Ltd Earnings Call TranscriptNov 07, 2023Earnings
- Q1 2024 Zydus Lifesciences Ltd Earnings Call TranscriptAug 11, 2023Earnings
- Q4 2023 Zydus Lifesciences Ltd Earnings Call TranscriptMay 18, 2023Earnings
- Q3 2023 Zydus Lifesciences Ltd Earnings Call TranscriptFeb 03, 2023Earnings
- Q2 2023 Zydus Lifesciences Ltd Earnings Call TranscriptNov 11, 2022Earnings
- Q1 2023 Zydus Lifesciences Ltd Earnings Call TranscriptAug 10, 2022Earnings
- Q4 2022 Zydus Lifesciences Ltd Earnings Call TranscriptMay 20, 2022Earnings
- Cadila Healthcare Ltd Extraordinary Shareholders Meeting TranscriptFeb 18, 2022
- Q3 2022 Cadila Healthcare Ltd Earnings Call TranscriptFeb 03, 2022Earnings
- Q2 2022 Cadila Healthcare Ltd Earnings Call TranscriptOct 29, 2021Earnings
- Cadila Healthcare Ltd to Discuss About the Emergency Use Authorization of ZyCov-D Vaccine Call TranscriptAug 23, 2021
- Q1 2022 Cadila Healthcare Ltd Earnings Call TranscriptAug 11, 2021Earnings
- Q4 2021 Cadila Healthcare Ltd Earnings Call TranscriptMay 27, 2021Earnings
- Cadila Healthcare Ltd to Discuss the Transaction of Zydus Cadila Entity to Sell Its India Focused Animal Health Business to Multiples Alternate Asset Management Call TranscriptMay 12, 2021
- Q3 2021 Cadila Healthcare Ltd Earnings Call TranscriptFeb 05, 2021Earnings
- Q2 2021 Cadila Healthcare Ltd Earnings Call TranscriptNov 02, 2020Earnings
- Q1 2021 Cadila Healthcare Ltd Earnings Call TranscriptAug 05, 2020Earnings
- Q4 2020 Cadila Healthcare Ltd Earnings Call TranscriptJun 19, 2020Earnings
- Q3 2020 Cadila Healthcare Ltd Earnings Call TranscriptFeb 05, 2020Earnings
- Q2 2020 Cadila Healthcare Ltd Earnings Call TranscriptNov 13, 2019Earnings
- Q1 2020 Cadila Healthcare Ltd Earnings Call TranscriptAug 09, 2019Earnings
- Q4 2019 Cadila Healthcare Ltd Earnings Call TranscriptMay 29, 2019Earnings
Q4 2023 Zydus Lifesciences Ltd Earnings Call Transcript
Good evening, ladies and gentlemen. Welcome to our post results teleconference for the fourth quarter and the financial year ended March 31, 2023. On today's call, we have with us Dr. Sharvil Patel, Managing Director; Mr. Nitin Parekh, Chief Financial Officer; Mr. Arvind Bothra, Senior Vice President, Investor Relations; and Mr. Alok Garg, Senior Vice President from the Managing Director's office.
I'm sure you would have gone through the financials and other material, which we have filed with the stock exchanges. To begin with, let me give you an overview of the performance in the year gone by. As we progressed through the year, all businesses demonstrated strong momentum and delivered double-digit growth consistently. Consequently, we closed the year on an encouraging note with overall.
Revenue growth of 14%. Our EBITDA growth of 16% was faster than the revenue growth, thanks to margin improvement achieved during the year. Our formulations business in India built further on the growth momentum from the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)